Walter & Keenan Wealth Management LLC Bristol Myers Squibb CO Transaction History
Walter & Keenan Wealth Management LLC
- $340 Million
- Q2 2025
A detailed history of Walter & Keenan Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Walter & Keenan Wealth Management LLC holds 7,530 shares of BMY stock, worth $345,852. This represents 0.1% of its overall portfolio holdings.
Number of Shares
7,530
Previous 9,341
19.39%
Holding current value
$345,852
Previous $569,000
38.84%
% of portfolio
0.1%
Previous 0.17%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,677Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.1M-
Vanguard Group Inc Valley Forge, PA195MShares$8.95 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.96 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...